Exciting news – Nature has published a collaboration between Salesforce and Tierra!Learn More 

Can we enable your COVID19 research?

We’re opening the Tierra platform to help scientists working on COVID19.

With our partners, we can produce hundreds of protein variants (eg. antigens, targets, diagnostic enzymes) from digital sequence to testable quantities at the ug-scale, purified to-specification. Potential uses include:

  • Production of viral antigens and antigen variants
  • Production of protein-based vaccine components
  • Screening of diagnostic enzymes and systems (eg. CRISPR-Cas-based, adapter based, transcription-factor based) for activity
  • Protein engineering in vitro (eg. domain shuffling, differential tagging) to specification

Contact us at info@tierrabiosciences.com or via the form below. Thanks!